please check plagerism of these paragraphs and paraphraze them to reduce plagerism: Spinal cord injury (SCI) is a devastating condition that affectsthe function of the spinal cord and its associated nerves, resulting in variousdegrees of sensory, motor and autonomic impairments ². SCI can be caused bytrauma, such as road accidents, falls or violence, or by non-traumatic causes,such as tumors, infections or degenerative diseases ³. According to the WorldHealth Organization (WHO), there are about 250,000 to 500,000 new cases of SCIevery year worldwide, with a global prevalence of 13 to 33 million peopleliving with SCI. SCI has a significant impact on the physical, psychologicaland social well-being of individuals and their families, as well as on thehealth care system and society at large. The mortality rate in people with TSCIis higher than that of normal people¹. In Iran, the incidence of TSCI wasestimated as 9 per 100,000 persons³. TSCI is a condition with multiplecomorbidities and considerable long-term disability often ensues when thespinal cord is damaged³. According to a study published on PubMed, theprevalence of spinal cord injury (SCI) in Iran is estimated to be 318.45 permillion ¹. 

The purpose of this narrative review is to summarize and synthesizethe existing knowledge on morbidity in SCI patients in Iran. Morbidity refersto the presence of disease or disability that affects the health status andquality of life of individuals. Morbidity in SCI patients can be classifiedinto two main types: primary and secondary. Primary morbidity refers to thedirect consequences of SCI on the nervous system, such as paralysis,spasticity, neuropathic pain or bladder and bowel dysfunction. Secondarymorbidity refers to the indirect consequences of SCI on other body systems ororgans, such as pressure ulcers, infections, osteoporosis, cardiovasculardisease or depression. Morbidity in SCI patients can vary depending on severalfactors, such as the level and completeness of injury, the time since injury,the age and gender of the patient, the availability and accessibility of healthcare services and the socio-cultural context.

The main objectives of this review are to: (1) describe theprevalence, risk factors, correlates and consequences of various morbidities inSCI patients in Iran; (2) compare and contrast the findings from differentstudies conducted in Iran or other countries; (3) identify the strengths andlimitations of the current literature; and (4) provide some implications andrecommendations for clinical practice, policy making, education and research.The scope of this review is limited to studies published in English or Persianfrom 2010 to 2023 that focused on morbidity in SCI patients in Iran. Theinclusion and exclusion criteria for selecting the studies are explained in themethods section. The structure of this review is as follows: first, we presentan overview of morbidity in SCI patients; second, we summarize the mainfindings from the studies included in our data; third, we discuss theimplications and recommendations based on our review; and finally, we concludewith a summary of our main points and findings.
Sent message. please check plagerism of these paragraphs: Spinal cord injury (SCI) is a devastating condition that affectsthe function of the spinal cord and its associated nerves, resulting in variousdegrees of sensory, motor and autonomic impairments ². SCI can be caused bytrauma, such as road accidents, falls or violence, or by non-traumatic causes,such as tumors, infections or degenerative diseases ³. According to the WorldHealth Organization (WHO), there are about 250,000 to 500,000 new cases of SCIevery year worldwide, with a global prevalence of 13 to 33 million peopleliving with SCI. SCI has a significant impact on the physical, psychologicaland social well-being of individuals and their families, as well as on thehealth care system and society at large. The mortality rate in people with TSCIis higher than that of normal people¹. In Iran, the incidence of TSCI wasestimated as 9 per 100,000 persons³. TSCI is a condition with multiplecomorbidities and considerable long-term disability often ensues when thespinal cord is damaged³. According to a study published on PubMed, theprevalence of spinal cord injury (SCI) in Iran is estimated to be 318.45 permillion ¹. The purpose of this narrative review is to summarize and synthesizethe existing knowledge on morbidity in SCI patients in Iran. Morbidity refersto the presence of disease or disability that affects the health status andquality of life of individuals. Morbidity in SCI patients can be classifiedinto two main types: primary and secondary. Primary morbidity refers to thedirect consequences of SCI on the nervous system, such as paralysis,spasticity, neuropathic pain or bladder and bowel dysfunction. Secondarymorbidity refers to the indirect consequences of SCI on other body systems ororgans, such as pressure ulcers, infections, osteoporosis, cardiovasculardisease or depression. Morbidity in SCI patients can vary depending on severalfactors, such as the level and completeness of injury, the time since injury,the age and gender of the patient, the availability and accessibility of healthcare services and the socio-cultural context. The main objectives of this review are to: (1) describe theprevalence, risk factors, correlates and consequences of various morbidities inSCI patients in Iran; (2) compare and contrast the findings from differentstudies conducted in Iran or other countries; (3) identify the strengths andlimitations of the current literature; and (4) provide some implications andrecommendations for clinical practice, policy making, education and research.The scope of this review is limited to studies published in English or Persianfrom 2010 to 2023 that focused on morbidity in SCI patients in Iran. Theinclusion and exclusion criteria for selecting the studies are explained in themethods section. The structure of this review is as follows: first, we presentan overview of morbidity in SCI patients; second, we summarize the mainfindings from the studies included in our data; third, we discuss theimplications and recommendations based on our review; and finally, we concludewith a summary of our main points and findings.